Likewise, a study by Palanichamy et al. [20] showed that the exogenous expression of IGF2BP3 increased the proliferation of bone marrow progenitor cells and provided them with a competitive survival advantage, and that IGF2BP3 was essential for the survival of several B-ALL cell lines. This evidence concerns the gene IGF2BP3 and acute lymphoblastic leukemia.